Bamifylline Hydrochloride is a xanthine-derivative bronchodilator related structurally to theophylline, used in the management of respiratory conditions involving bronchospasm. Simson Pharma's Bamifylline Hydrochloride reference standard supports compendial QC for this respiratory therapeutic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bamifylline hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
